Elequin Capital’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-402,385
Closed -$7.86M 685
2022
Q4
$7.86M Buy
402,385
+162,012
+67% +$3.26M 2.21% 5
2022
Q3
$5.03M Buy
+240,373
New +$6.87M 1.88% 7

Elequin Capital's ELAT Position: Q1 2023 in Review

Elequin Capital sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 402,385 shares — an estimated $7.86M sold.

Elequin Capital first reported a position in ELAT in Q3 2022 and held it in 2 quarters. The position peaked at $7.86M in Q4 2022. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • Elequin Capital reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • Elequin Capital sold 402,385 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $7.86M.
  • Elequin Capital first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2022 and held it in 2 quarters.
  • Elequin Capital's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $7.86M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.